Applied Minerals, Inc.

2022 Q4 Form 10-Q Financial Statement

#000157587222001194 Filed on November 30, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $729.8K $206.1K
YoY Change 254.13% 178.8%
Cash & Equivalents $729.8K $206.1K
Short-Term Investments
Other Short-Term Assets $20.45K $32.09K
YoY Change -36.27% 36.9%
Inventory
Prepaid Expenses
Receivables $92.58K $24.26K
Other Receivables $0.00 $0.00
Total Short-Term Assets $842.9K $262.4K
YoY Change 221.16% 19.76%
LONG-TERM ASSETS
Property, Plant & Equipment $500.0K $601.5K
YoY Change -16.87% 20.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $297.3K $336.3K
YoY Change -11.59% 0.05%
Total Long-Term Assets $831.2K $937.8K
YoY Change -11.36% -6.08%
TOTAL ASSETS
Total Short-Term Assets $842.9K $262.4K
Total Long-Term Assets $831.2K $937.8K
Total Assets $1.674M $1.200M
YoY Change 39.48% -1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.306M $2.829M
YoY Change -53.83% 5.51%
Accrued Expenses $623.7K $515.6K
YoY Change 20.97% -8.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $264.5K
YoY Change -100.0% 18.56%
Long-Term Debt Due $48.42M $11.81K
YoY Change 409908.38% -80.11%
Total Short-Term Liabilities $50.35M $3.621M
YoY Change 1290.63% 2.72%
LONG-TERM LIABILITIES
Long-Term Debt $21.37K $46.50M
YoY Change -99.95% 3.99%
Other Long-Term Liabilities $1.000M $1.000M
YoY Change 0.0% 1631.9%
Total Long-Term Liabilities $1.021M $47.50M
YoY Change -97.85% 6.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.35M $3.621M
Total Long-Term Liabilities $1.021M $47.50M
Total Liabilities $51.37M $51.12M
YoY Change 0.49% 5.84%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $367.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$49.70M -$49.92M
YoY Change
Total Liabilities & Shareholders Equity $1.674M $1.200M
YoY Change 39.48% -1.43%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
amnl Non Cash Lease Expense
NonCashLeaseExpense
28111
dei City Area Code
CityAreaCode
435
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84628
us-gaap Share Based Compensation
ShareBasedCompensation
213199
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000008328
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-31380
dei Entity Registrant Name
EntityRegistrantName
APPLIED MINERALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0096527
dei Entity Address Address Line1
EntityAddressAddressLine1
1200 Silver City Road, PO Box 432
dei Entity Address City Or Town
EntityAddressCityOrTown
Eureka
dei Local Phone Number
LocalPhoneNumber
433-2059
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
390842696
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
729828
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74253
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92575
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34309
CY2022Q3 amnl Deposits And Prepaid Expenses
DepositsAndPrepaidExpenses
20452
CY2021Q4 amnl Deposits And Prepaid Expenses
DepositsAndPrepaidExpenses
161999
CY2022Q3 us-gaap Assets Current
AssetsCurrent
842855
CY2021Q4 us-gaap Assets Current
AssetsCurrent
270561
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
500000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
500000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28111
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
33893
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
42821
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
297320
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
336328
CY2022Q3 us-gaap Other Assets
OtherAssets
297320
CY2021Q4 us-gaap Other Assets
OtherAssets
336328
CY2022Q3 us-gaap Assets
Assets
1674068
CY2021Q4 us-gaap Assets
Assets
1177821
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1306219
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3017454
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
623690
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
372028
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
365529
CY2022Q3 amnl Long Term Debts Current
LongTermDebtsCurrent
48298591
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
110880
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
112835
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12519
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11986
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29085
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
50351899
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3543388
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
681102
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
47004480
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
1000000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1000000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
21373
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
30835
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1021373
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
48035315
CY2022Q3 us-gaap Liabilities
Liabilities
51373272
CY2021Q4 us-gaap Liabilities
Liabilities
51578703
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
164000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
164000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
262000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
262000
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
78
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
262
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
366974683
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
366974683
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217655150
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
217655150
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
208818846
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
208818846
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
366974
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
217654
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76937697
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74686581
CY2022Q3 amnl Accumulated Deficit Prior To The Exploration Stage
AccumulatedDeficitPriorToTheExplorationStage
-20009496
CY2021Q4 amnl Accumulated Deficit Prior To The Exploration Stage
AccumulatedDeficitPriorToTheExplorationStage
-20009496
CY2022Q3 amnl Accumulated Deficit During The Exploration Stage
AccumulatedDeficitDuringTheExplorationStage
-106994457
CY2021Q4 amnl Accumulated Deficit During The Exploration Stage
AccumulatedDeficitDuringTheExplorationStage
-105295883
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49699204
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-50400882
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1674068
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1177821
CY2022Q3 us-gaap Revenues
Revenues
111688
CY2021Q3 us-gaap Revenues
Revenues
360815
us-gaap Revenues
Revenues
295838
us-gaap Revenues
Revenues
1099980
CY2022Q3 us-gaap Production Costs
ProductionCosts
140123
CY2021Q3 us-gaap Production Costs
ProductionCosts
434225
us-gaap Production Costs
ProductionCosts
451418
us-gaap Production Costs
ProductionCosts
1315350
CY2022Q3 us-gaap Exploration Costs
ExplorationCosts
16098
CY2021Q3 us-gaap Exploration Costs
ExplorationCosts
47866
us-gaap Exploration Costs
ExplorationCosts
266111
us-gaap Exploration Costs
ExplorationCosts
175715
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
341847
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
443503
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1082953
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1244975
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
498068
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
925594
us-gaap Operating Expenses
OperatingExpenses
1800482
us-gaap Operating Expenses
OperatingExpenses
2736040
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-386380
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-564779
us-gaap Operating Income Loss
OperatingIncomeLoss
-1504644
us-gaap Operating Income Loss
OperatingIncomeLoss
-1636060
CY2022Q3 us-gaap Interest Expense
InterestExpense
643933
CY2021Q3 us-gaap Interest Expense
InterestExpense
474579
us-gaap Interest Expense
InterestExpense
1596548
us-gaap Interest Expense
InterestExpense
1401878
CY2021Q3 amnl Gain On Forgiveness Of Paycheck Protection Program
GainOnForgivenessOfPaycheckProtectionProgram
0
amnl Gain On Forgiveness Of Paycheck Protection Program
GainOnForgivenessOfPaycheckProtectionProgram
0
amnl Gain On Forgiveness Of Paycheck Protection Program
GainOnForgivenessOfPaycheckProtectionProgram
223075
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1938000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1938000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
716800
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20308
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
535382
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114662
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
577267
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-454271
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-193930
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1064141
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
190887
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1019050
us-gaap Net Income Loss
NetIncomeLoss
-1698574
us-gaap Net Income Loss
NetIncomeLoss
-2700201
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
321090805
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
321090805
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
199138961
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
199138961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
276820927
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
276820927
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194202348
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194202348
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-52047403
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
51929
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
51929
CY2022Q3 amnl Stock Issued During Period Value Issued For Part Of Settlement Of Liability
StockIssuedDuringPeriodValueIssuedForPartOfSettlementOfLiability
74667
CY2022Q3 amnl Adjustments To Additional Paid In Capital Forgiveness Of Related Party Liabilities
AdjustmentsToAdditionalPaidInCapitalForgivenessOfRelatedPartyLiabilities
1991061
CY2022Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
62000
CY2022Q3 amnl Adjustments To Additional Paid In Capital For Legal Expense Related To Asset Sale
AdjustmentsToAdditionalPaidInCapitalForLegalExpenseRelatedToAssetSale
-20000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
49584
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
190887
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49699204
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-49251882
CY2021Q3 amnl Preferred Stock Value Issued Upon Conversion
PreferredStockValueIssuedUponConversion
700
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
200000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
112525
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
112525
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
147172
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1019050
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-49923060
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-50400882
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
75000
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
77876
us-gaap Dividends Preferred Stock
DividendsPreferredStock
77876
amnl Stock Issued During Period Value Issued For Part Of Settlement Of Liability
StockIssuedDuringPeriodValueIssuedForPartOfSettlementOfLiability
128445
amnl Adjustments To Additional Paid In Capital Forgiveness Of Related Party Liabilities
AdjustmentsToAdditionalPaidInCapitalForgivenessOfRelatedPartyLiabilities
1991061
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
62000
amnl Adjustments To Additional Paid In Capital For Legal Expense Related To Asset Sale
AdjustmentsToAdditionalPaidInCapitalForLegalExpenseRelatedToAssetSale
-20000
amnl Stock Issued During Period Value Issued For Debt Issuance Cost
StockIssuedDuringPeriodValueIssuedForDebtIssuanceCost
1740
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
70000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
92006
us-gaap Net Income Loss
NetIncomeLoss
-1698574
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49699204
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-47829437
amnl Preferred Stock Value Issued Upon Conversion
PreferredStockValueIssuedUponConversion
8380
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
385000
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
225137
us-gaap Dividends Preferred Stock
DividendsPreferredStock
225137
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
58140
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
155058
us-gaap Net Income Loss
NetIncomeLoss
-2700201
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-49923060
us-gaap Net Income Loss
NetIncomeLoss
-1698574
us-gaap Net Income Loss
NetIncomeLoss
-2700201
us-gaap Depreciation
Depreciation
8928
us-gaap Depreciation
Depreciation
4869
amnl Amortization Of Debt Discount
AmortizationOfDebtDiscount
9566
amnl Amortization Of Debt Discount
AmortizationOfDebtDiscount
0
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
315573
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
299426
us-gaap Paid In Kind Interest
PaidInKindInterest
1238435
us-gaap Paid In Kind Interest
PaidInKindInterest
1036691
amnl Stock Issued For Settlement Of Liability
StockIssuedForSettlementOfLiability
-128445
amnl Stock Issued For Settlement Of Liability
StockIssuedForSettlementOfLiability
0
us-gaap Share Based Compensation
ShareBasedCompensation
162006
amnl Non Cash Lease Expense
NonCashLeaseExpense
80518
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
50000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
amnl Gain Loss On Sale Of Iron Oxide Assets
GainLossOnSaleOfIronOxideAssets
1938000
amnl Gain Loss On Sale Of Iron Oxide Assets
GainLossOnSaleOfIronOxideAssets
0
us-gaap Dividends
Dividends
0
us-gaap Dividends
Dividends
8379
amnl Gain On Forgiveness Of Paycheck Protection Program
GainOnForgivenessOfPaycheckProtectionProgram
0
amnl Gain On Forgiveness Of Paycheck Protection Program
GainOnForgivenessOfPaycheckProtectionProgram
223075
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
58266
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-43302
amnl Increase Decrease In Deposits And Prepaid Expense
IncreaseDecreaseInDepositsAndPrepaidExpense
-180555
amnl Increase Decrease In Deposits And Prepaid Expense
IncreaseDecreaseInDepositsAndPrepaidExpense
-158493
amnl Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
29085
amnl Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
82584
amnl Increase Decrease Financing Lease Liabilities
IncreaseDecreaseFinancingLeaseLiabilities
-9076
amnl Increase Decrease Financing Lease Liabilities
IncreaseDecreaseFinancingLeaseLiabilities
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
271591
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
187151
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1439791
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-973832
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
50000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0
amnl Proceeds From Sale Of Iron Oxide Assets
ProceedsFromSaleOfIronOxideAssets
1938000
amnl Proceeds From Sale Of Iron Oxide Assets
ProceedsFromSaleOfIronOxideAssets
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1988000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5882
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6029
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
200000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
amnl Proceeds From Payment Protection Loan
ProceedsFromPaymentProtectionLoan
0
amnl Proceeds From Payment Protection Loan
ProceedsFromPaymentProtectionLoan
264472
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
90917
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
75000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
385000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
amnl Payment Of Insurance Financing
PaymentOfInsuranceFinancing
-112835
amnl Payment Of Insurance Financing
PaymentOfInsuranceFinancing
-133081
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
107366
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
510362
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
655575
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-463470
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74253
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
669560
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
729828
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206090
us-gaap Interest Paid Net
InterestPaidNet
31470
us-gaap Interest Paid Net
InterestPaidNet
6037
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
51733
amnl Boral Settlement Payable
BoralSettlementPayable
-8235
amnl Boral Settlement Payable
BoralSettlementPayable
0
amnl Forgiveness Of Related Parties Liabilities
ForgivenessOfRelatedPartiesLiabilities
1991061
amnl Forgiveness Of Related Parties Liabilities
ForgivenessOfRelatedPartiesLiabilities
0
us-gaap Dividends Preferred Stock
DividendsPreferredStock
77876
us-gaap Dividends Preferred Stock
DividendsPreferredStock
225137
us-gaap Notes Issued1
NotesIssued1
986774
us-gaap Notes Issued1
NotesIssued1
943990
amnl Stock Issued For Cashless Options Exercised
StockIssuedForCashlessOptionsExercised
1740
amnl Stock Issued For Cashless Options Exercised
StockIssuedForCashlessOptionsExercised
3836
amnl Common Stock Issued Upon Conversion Of Preferred Stock Series B
CommonStockIssuedUponConversionOfPreferredStockSeriesB
96798
amnl Common Stock Issued Upon Conversion Of Preferred Stock Series B
CommonStockIssuedUponConversionOfPreferredStockSeriesB
0
CY2022Q3 amnl Waiver Fee Expenses
WaiverFeeExpenses
375000
amnl Waiver Fee Expenses
WaiverFeeExpenses
750000
CY2022Q3 amnl Accrued Unpaid Fees And Compensation Cost
AccruedUnpaidFeesAndCompensationCost
1900000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3854653
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.79
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52936192
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.19
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates. As of September 30, 2022, the extent to which the COVID-19 pandemic will impact our business going forward depends on numerous dynamic factors, which we cannot reliably predict. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As the events continue to evolve with respect to the pandemic, our estimates may materially change in future periods.</div></div>
us-gaap Interest Expense Debt
InterestExpenseDebt
2626
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk</div></div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Cash balances, accounts receivable and derivative financial instruments are financial instruments potentially subject to credit risk. Cash and cash equivalents are maintained in bank deposit accounts, which, at times, may exceed the federally insured limits. Management periodically reviews and assesses the financial condition of the banks to mitigate the risk of loss.</div></div> <div style="font-size: 12pt; margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; background: none; letter-spacing: 0px; top: 0px;;display:inline;">For the nine months ended September 30, 2022 and 2021, revenues from the Company’s largest customer</div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">s (each representing 10% or more of total</div></div> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">revenue)<div style="display:inline;"> </div></div></div><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; background: none; letter-spacing: 0px; top: 0px;;display:inline;">accounted for 68% and 67% of total revenues, respectively. As of September 30, 2022 and 2021, amounts owed from these customers comprised 90% and 98% of accounts receivable, respectively.</div></div>
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
9528689
amnl Cost Of Services Oil Gas
CostOfServicesOilGas
297000
CY2021Q4 us-gaap Notes Payable
NotesPayable
112835
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
110880
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
112835
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
us-gaap Interest Expense Debt
InterestExpenseDebt
14241
CY2021Q2 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P4Y
CY2021Q2 amnl Finance Leases Rent Expense Minimum Rentals
FinanceLeasesRentExpenseMinimumRentals
1175
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
16290
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52790845
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.001
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
297320
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
336328
CY2022Q3 us-gaap Notes Payable
NotesPayable
110880
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
The conversion price (the “Conversion Price”) shall equal the 61% multiplied by the Market Price (representing a discount rate of 39%). “Market Price” means the lowest Trading Price for the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.
amnl Preferred Stock Share Issued Upon Conversion
PreferredStockShareIssuedUponConversion
20164153
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
70000
CY2022Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
52936192
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y10M20D
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.19
CY2022Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
52936192
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P2Y10M20D
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.19
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0

Files In Submission

Name View Source Status
0001575872-22-001194-index-headers.html Edgar Link pending
0001575872-22-001194-index.html Edgar Link pending
0001575872-22-001194.txt Edgar Link pending
0001575872-22-001194-xbrl.zip Edgar Link pending
amnl-20220930.htm Edgar Link pending
amnl-20220930.xsd Edgar Link pending
amnl-20220930_cal.xml Edgar Link unprocessable
amnl-20220930_def.xml Edgar Link unprocessable
amnl-20220930_lab.xml Edgar Link unprocessable
amnl-20220930_htm.xml Edgar Link completed
app056_ex10-1.htm Edgar Link pending
app056_ex10-10.htm Edgar Link pending
app056_ex10-2.htm Edgar Link pending
app056_ex10-3.htm Edgar Link pending
app056_ex10-4.htm Edgar Link pending
app056_ex10-5.htm Edgar Link pending
app056_ex10-6.htm Edgar Link pending
app056_ex10-7.htm Edgar Link pending
app056_ex10-8.htm Edgar Link pending
app056_ex10-9.htm Edgar Link pending
app056_ex31-1.htm Edgar Link pending
app056_ex31-2.htm Edgar Link pending
app056_ex32-1.htm Edgar Link pending
app056_ex32-2.htm Edgar Link pending
app056_ex95.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
amnl-20220930_pre.xml Edgar Link unprocessable